CERo Therapeutics Holdings, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 6.1% | 6.1% | -1.6% |
| FY2023 | 17.3% | 17.3% | -142.2% |
| FY2024 | 408.1% | 408.1% | -124.6% |
| FY2025 | 365.7% | 365.7% | -547.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 6.1% | 6.1% | -1.6% |
| FY2023 | 17.3% | 17.3% | -142.2% |
| FY2024 | 408.1% | 408.1% | -124.6% |
| FY2025 | 365.7% | 365.7% | -547.1% |